0.00Open1.50Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover3159.21%IV-7.33%PremiumMay 17, 2024Expiry Date1.22Intrinsic Value100Multiplier-5DDays to Expiry0.28Time Value100Contract SizeAmericanOptions Type-0.8954Delta0.2048Gamma2.52Leverage Ratio-3.4231Theta0.0000Rho-2.25Eff Leverage0.0001Vega
NRX Pharmaceuticals Stock Discussion
Catching the attention of the pharmaceutical industry and investors alike, NRx Pharmaceuticals (Nasdaq: NRXP), a clinical-stage pharmaceutical company, has announced final clinical trial results showcasing a superior safety profile of NRX-101 over lurasidon...
NRX Pharmaceuticals (Nasdaq:Nrxp) Announces Final Clinical Trial Results: Superior Safety Combined With Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression
No comment yet